PK

Pawan Kumar Singh

Active Director Director DIN 08680162
DIN 08680162 First appointment Jan 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Pawan Kumar Singh

Data last updated:

Pawan Kumar Singh is a Director at Segmed Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare. Segmed Pharmaceuticals Private Limited reported revenue of ₹5.4 Lakh (FY 2024).

DIN 08680162
Primary Designation Director
Industry Healthcare
First Appointment 27 Jan 2020
Oldest Company Age 6 yrs
Largest company Segmed Pharmaceuticals Private Limited · ₹5.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jan 20202020₹5.4 Lakh (FY 2024)Active

Board colleagues of Pawan Kumar Singh

Directorship timeline

Open interactive timeline →
Segmed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pawan Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Kumar Singh

Pawan Kumar Singh currently holds 1 directorship: Segmed Pharmaceuticals Private Limited (Director, since 27 Jan 2020, revenue ₹5.4 Lakh (FY 2024)).

Pawan Kumar Singh was first appointed on 27 Jan 2020 as Director at Segmed Pharmaceuticals Private Limited.

The current boards of Pawan Kumar Singh's companies include Neeraj Srivastava (Segmed Pharmaceuticals Private Limited), Shailendra Kumar Dwivedi (Segmed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available